Editorial Commentary: Dead or Alive: Can Viability Staining Predict Response to Tuberculosis Treatment?

Overview

Journal Clin Infect Dis

Publisher Oxford University Press

Specialty Infectious Diseases

Date 2014 Dec 25

PMID 25537871

Citations 4

Authors

Stephen D Lawn

Mark P Nicol

Affiliations

Soon will be listed here.

Citing Articles

Statistical Investigation of High Culture Contamination Rates in Mycobacteriology Laboratory.

Adam M, Ebraheem R, Bedri S Front Microbiol. 2022; 13:789725.

PMID: 35602070 PMC: 9120365. DOI: 10.3389/fmicb.2022.789725.

New insights into the kinetics of bacterial growth and decay in pig manure-wheat straw aerobic composting based on an optimized PMA-qPCR method.

Ge J, Huang G, Sun X, Yin H, Han L Microb Biotechnol. 2019; 12(3):502-514.

PMID: 30838800 PMC: 6465228. DOI: 10.1111/1751-7915.13380.

Sputum Microscopy With Fluorescein Diacetate Predicts Tuberculosis Infectiousness.

Datta S, Sherman J, Tovar M, Bravard M, Valencia T, Montoya R J Infect Dis. 2017; 216(5):514-524.

PMID: 28510693 PMC: 5853787. DOI: 10.1093/infdis/jix229.

Rapid culture-based diagnosis of pulmonary tuberculosis in developed and developing countries.

Asmar S, Drancourt M Front Microbiol. 2015; 6:1184.

PMID: 26579092 PMC: 4630581. DOI: 10.3389/fmicb.2015.01184.

References

Vidal R, Martin-Casabona N, Juan A, Falgueras T, Miravitlles M . Incidence and significance of acid-fast bacilli in sputum smears at the end of antituberculous treatment. Chest. 1996; 109(6):1562-5. DOI: 10.1378/chest.109.6.1562. View

Kvach J, Veras J . A fluorescent staining procedure for determining the viability of mycobacterial cells. Int J Lepr Other Mycobact Dis. 1982; 50(2):183-92. View

Kvach J, Munguia G, Strand S . Staining tissue-derived Mycobacterium leprae with fluorescein diacetate and ethidium bromide. Int J Lepr Other Mycobact Dis. 1984; 52(2):176-82. View

MOORE A, Kirk S, Callister S, Mazurek G, Schell R . Safe determination of susceptibility of Mycobacterium tuberculosis to antimycobacterial agents by flow cytometry. J Clin Microbiol. 1999; 37(3):479-83. PMC: 84439. DOI: 10.1128/JCM.37.3.479-483.1999. View

Al-Moamary M, Black W, Bessuille E, Elwood R, Vedal S . The significance of the persistent presence of acid-fast bacilli in sputum smears in pulmonary tuberculosis. Chest. 1999; 116(3):726-31. DOI: 10.1378/chest.116.3.726. View

Hamid Salim A, Aung K, Hossain M, Van Deun A . Early and rapid microscopy-based diagnosis of true treatment failure and MDR-TB. Int J Tuberc Lung Dis. 2006; 10(11):1248-54. View

Li L, Mahan C, Palaci M, Horter L, Loeffelholz L, Johnson J . Sputum Mycobacterium tuberculosis mRNA as a marker of bacteriologic clearance in response to antituberculosis therapy. J Clin Microbiol. 2009; 48(1):46-51. PMC: 2812283. DOI: 10.1128/JCM.01526-09. View

Minion J, Pai M . Bacteriophage assays for rifampicin resistance detection in Mycobacterium tuberculosis: updated meta-analysis. Int J Tuberc Lung Dis. 2010; 14(8):941-51. View

Schramm B, Hewison C, Bonte L, Jones W, Camelique O, Ruangweerayut R . Field evaluation of a simple fluorescence method for detection of viable Mycobacterium tuberculosis in sputum specimens during treatment follow-up. J Clin Microbiol. 2012; 50(8):2788-90. PMC: 3421534. DOI: 10.1128/JCM.01232-12. View

10.

Van Deun A, Maug A, Hossain A, Gumusboga M, de Jong B . Fluorescein diacetate vital staining allows earlier diagnosis of rifampicin-resistant tuberculosis. Int J Tuberc Lung Dis. 2012; 16(9):1174-9. DOI: 10.5588/ijtld.11.0166. View

11.

Weigel K, Jones K, Do J, Witt J, Chung J, Valcke C . Molecular viability testing of bacterial pathogens from a complex human sample matrix. PLoS One. 2013; 8(1):e54886. PMC: 3554692. DOI: 10.1371/journal.pone.0054886. View

12.

Lawn S, Mwaba P, Bates M, Piatek A, Alexander H, Marais B . Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis. 2013; 13(4):349-61. PMC: 4844338. DOI: 10.1016/S1473-3099(13)70008-2. View

13.

Friedrich S, Rachow A, Saathoff E, Singh K, Mangu C, Dawson R . Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment. Lancet Respir Med. 2014; 1(6):462-70. DOI: 10.1016/S2213-2600(13)70119-X. View

14.

Cangelosi G, Meschke J . Dead or alive: molecular assessment of microbial viability. Appl Environ Microbiol. 2014; 80(19):5884-91. PMC: 4178667. DOI: 10.1128/AEM.01763-14. View

15.

Datta S, Sherman J, Bravard M, Valencia T, Gilman R, Evans C . Clinical evaluation of tuberculosis viability microscopy for assessing treatment response. Clin Infect Dis. 2014; 60(8):1186-95. PMC: 4370166. DOI: 10.1093/cid/ciu1153. View

16.

Katoch V, Katoch K, Ramanathan U, Sharma V, Shivannavar C, Datta A . Effect of chemotherapy on viability of Mycobacterium leprae as determined by ATP content, morphological index and FDA-EB fluorescent staining. Int J Lepr Other Mycobact Dis. 1989; 57(3):615-21. View

17.

Norden M, Kurzynski T, Bownds S, Callister S, Schell R . Rapid susceptibility testing of Mycobacterium tuberculosis (H37Ra) by flow cytometry. J Clin Microbiol. 1995; 33(5):1231-7. PMC: 228136. DOI: 10.1128/jcm.33.5.1231-1237.1995. View

18.

Harada S, Numata N . [Application of FDA/EB staining for the detection of viable or non-viable mycobacteria in clinical specimens]. Kekkaku. 1992; 67(2):113-7. View